Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Clinical trial NCT06712355 · RECRUITING

Trial details

NCT number: NCT06712355
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Extensive-stage Small-cell Lung Cancer

Start date: 2025-02-03
Primary completion: 2028-12-01
Enrollment: 621

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.